Retinal Ganglion Cells - Forthcoming Restoration of Epigenetically Induced Damage
Forthcoming Restoration of Epigenetically Induced Damage to Retinal Ganglion Cells Retinal ganglion cell degeneration is one the baseis for a number of ocular neuropathies and diseases, including glaucoma (Corral-Domenge, 2022; Khatib & Martin, 2017; Munemasa & Kitaoka, 2013). As of 2019, 2.2 billion people are blind or have visual problems (World Health Organization, 2019), according to SEE International (2022), 76 million people will suffer from glaucoma, and it is predicted that there will be a 74% increase in glaucoma the next 20 years. A number of causes for retinal ganglion cell degeneration have been proposed that also include immune dysfunction, reactive oxygen species (ROS), and mitochondrial pathology (Munemasa & Kitaoka, 2013). There are currently no approved cures for retinal ganglion cell degradation in glaucoma cases, the standard treatment being lowering of intraocular pressure to assist in preventing further damage (Khatib & Martin, 2017; Munemas...